| PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy P Komirishetty, A Areti, VG Yerra, PK Ruby, SS Sharma, R Gogoi, R Sistla, ... Life sciences 150, 50-60, 2016 | 55 | 2016 |
| Oxidative stress and diabetic neuropathy: current status of antioxidants G Negi, A Kumar, RP Joshi, PK Ruby, SS Sharma Institute of Integrative Omics and Applied Biotechnology 2 (6), 71-78, 2011 | 50 | 2011 |
| Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease R Malayandi, PK Kondamudi, PK Ruby, D Aggarwal Drug Delivery and Translational Research 4 (2), 187-202, 2014 | 29 | 2014 |
| Critical attributes of transdermal drug delivery system (TDDS)–a generic product development review PK Ruby, SM Pathak, D Aggarwal Drug development and industrial pharmacy 40 (11), 1421-1428, 2014 | 23 | 2014 |
| In Vitro and In Vivo Equivalence Testing of Nanoparticulate Intravenous Formulations SM Pathak, PK Ruby, D Aggarwal Drug research 64 (04), 169-176, 2014 | 2 | 2014 |
